Altana starts legal actions to fight generic medication competition Altana AG cipro or zithromax.

Altana starts legal actions to fight generic medication competition Altana AG, Germany’s fifth-biggest medication maker, is facing a generic challenge from an unnamed competitor to its Protonix ulcer medication. Altana is currently readying its patent infringement fit to stave off the generic competition. Altana and its own US partner Wyeth are assured that the patent, which expires in July 2010, will endure the challenge cipro or zithromax . Protonix generated $2.84 billion in worldwide sales this past year.

Changed state physiology drug advancement platform to treat an array of human conditions David H. Fater, CEO of Vicor Systems, Inc. , today announced that on July 23, 2009, the Australian Patent Office issued it a Deed of Letters Patent for its altered state physiology drug development system. Vicor also has filed several patents linked to the advancement of peptides and proteins produced from ‘state-dependent’ physiologies to advance the treatment of a multitude of human circumstances. Related StoriesBreakthrough developments on new molecular system may lead to Parkinson's treatmentsOxford professor wins Heinrich Wieland Prize for pioneering technique that assists control nerve cells with lightU-M study suggests new therapeutic technique for treating Duchene muscular dystrophyThe Australian Deed of Letters Patent is valid through February 5, 2023 .

Other articles from category "cosmetic surgery":

Random articles